Sunshine Act Meeting, 8584-8585 [2022-03291]
Download as PDF
lotter on DSK11XQN23PROD with NOTICES1
8584
Federal Register / Vol. 87, No. 31 / Tuesday, February 15, 2022 / Notices
collection burden for small business
concerns with fewer than 25
employees.’’ The Commission may not
conduct or sponsor a collection of
information unless it displays a
currently valid Office of Management
and Budget (OMB) control number. No
person shall be subject to any penalty
for failing to comply with a collection
of information subject to the PRA that
does not display a valid OMB control
number.
DATES: Written comments and
recommendations for the proposed
information collection should be
submitted on or before March 17, 2022.
ADDRESSES: Comments should be sent to
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
30-day Review—Open for Public
Comments’’ or by using the search
function. Your comment must be
submitted into www.reginfo.gov per the
above instructions for it to be
considered. In addition to submitting in
www.reginfo.gov also send a copy of
your comment on the proposed
information collection to Nicole Ongele,
FCC, via email to PRA@fcc.gov and to
Nicole.Ongele@fcc.gov. Include in the
comments the OMB control number as
shown in the SUPPLEMENTARY
INFORMATION below.
FOR FURTHER INFORMATION CONTACT: For
additional information or copies of the
information collection, contact Nicole
Ongele at (202) 418–2991. To view a
copy of this information collection
request (ICR) submitted to OMB: (1) Go
to the web page https://www.reginfo.gov/
public/do/PRAMain, (2) look for the
section of the web page called
‘‘Currently Under Review,’’ (3) click on
the downward-pointing arrow in the
‘‘Select Agency’’ box below the
‘‘Currently Under Review’’ heading, (4)
select ‘‘Federal Communications
Commission’’ from the list of agencies
presented in the ‘‘Select Agency’’ box,
(5) click the ‘‘Submit’’ button to the
right of the ‘‘Select Agency’’ box, (6)
when the list of FCC ICRs currently
under review appears, look for the Title
of this ICR and then click on the ICR
Reference Number. A copy of the FCC
submission to OMB will be displayed.
SUPPLEMENTARY INFORMATION: As part of
its continuing effort to reduce
paperwork burdens, as required by the
Paperwork Reduction Act (PRA) of 1995
(44 U.S.C. 3501–3520), the FCC invited
the general public and other Federal
Agencies to take this opportunity to
comment on the following information
collection. Comments are requested
concerning: (a) Whether the proposed
collection of information is necessary
VerDate Sep<11>2014
20:12 Feb 14, 2022
Jkt 256001
for the proper performance of the
functions of the Commission, including
whether the information shall have
practical utility; (b) the accuracy of the
Commission’s burden estimates; (c)
ways to enhance the quality, utility, and
clarity of the information collected; and
(d) ways to minimize the burden of the
collection of information on the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Pursuant to the Small Business
Paperwork Relief Act of 2002, Public
Law 107–198, see 44 U.S.C. 3506(c)(4),
the FCC seeks specific comment on how
it might ‘‘further reduce the information
collection burden for small business
concerns with fewer than 25
employees.’’
OMB Control Number: 3060–XXXX.
Title: Preparation of Annual Reports
to Congress for the Collection & Use of
Fees for 988 Services by States & Other
Jurisdictions Under the National
Suicide Hotline Designation Act of
2020.
Form Number: N/A.
Type of Review: New information
collection.
Respondents: State, Local, or Tribal
governments.
Number of Respondents and
Responses: 630 respondents; 630
responses.
Estimated Time per Response: 55
hours.
Frequency of Response: Annual
reporting requirement.
Obligation to Respond: Voluntary.
Statutory authority for this information
collection is contained in National
Suicide Hotline Designation Act of
2020, Public Law 116–172, 134 Stat. 832
(2020) (988 Act).
Total Annual Burden: 34,650 hours.
Total Annual Cost: No Cost.
Privacy Act Impact Assessment: No
impact(s).
Nature and Extent of Confidentiality:
The Commission will consider the
potential confidentiality of any
information submitted, particularly
where public release of such
information could raise security
concerns (e.g., granular location
information). Respondents may request
materials or information submitted to
the Commission or to the Administrator
be withheld from public inspection
under 47 CFR 0.459 of the
Commission’s rules.
Needs and Uses: This information
collection enables the Federal
Communications Commission
(Commission) to fulfill its continuing
obligations under the National Suicide
Hotline Designation Act of 2020, Public
Law 116–172, 134 Stat. 832 (2020) (988
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
Act), to submit an annual ‘‘Fee
Accountability Report’’ to the
Committees on Commerce, Science, and
Transportation and Appropriations of
the Senate, and the Committees on
Energy and Commerce and
Appropriations of the House of
Representatives, detailing ‘‘the status in
each State, political subdivision of a
State, Indian Tribe, or village or regional
corporation serving’’ an Alaska Native
Claims Settlement Act region, of the
collection and distribution of fees or
charges for ‘‘the support or
implementation of 9–8–8 services,’’
including ‘‘findings on the amount of
revenues obligated or expended by each
[state, political entity, and subdivision]
for any purpose other than the purpose
for which any such fees or charges are
specified.’’ (988 Act, 134 Stat. at 833–
34.)
The Commission will collect
information for the preparation of the
annual Fee Accountability Report
through a survey, to be distributed via
electronic mail, that appropriate
officials of States and political
subdivisions thereof, Indian Tribes, and
village or regional corporations serving
a region established pursuant to the
Alaska Native Claims Settlement Act, as
amended (43 U.S.C. 1601 et seq.) can
use to submit data pertaining to the
collection and distribution of revenues
from fees and charges for the support or
implementation of 988 services,
including the use of such collected fees
and charges for any purpose other than
for the support or implementation of
988 services. In addition, consistent
with the definition of ‘‘State’’ set forth
in 47 U.S.C. 153(40) of the
Communications Act, the Commission
will collect this information from states
as well as the District of Columbia and
the inhabited U.S. Territories and
possessions.
Federal Communications Commission.
Marlene Dortch,
Secretary, Office of the Secretary.
[FR Doc. 2022–03154 Filed 2–14–22; 8:45 am]
BILLING CODE 6712–01–P
FEDERAL ELECTION COMMISSION
Sunshine Act Meeting
Thursday, February 17,
2022 at 11:00 a.m.
TIME AND DATE:
1050 First Street NE,
Washington, DC. (This meeting will be
a virtual meeting).
PLACE:
This meeting will be closed to
the public.
STATUS:
E:\FR\FM\15FEN1.SGM
15FEN1
Federal Register / Vol. 87, No. 31 / Tuesday, February 15, 2022 / Notices
Audit
conducted pursuant to 52 U.S.C.
30111(b).
*
*
*
*
*
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
CONTACT PERSON FOR MORE INFORMATION:
[Docket No. FDA–2022–N–0072]
MATTERS TO BE CONSIDERED:
Food and Drug Administration
Judith Ingram, Press Officer. Telephone:
(202) 694–1220.
Authority: Government in the
Sunshine Act, 5 U.S.C. 552b.
Laura E. Sinram,
Acting Secretary and Clerk of the
Commission.
Data Standards; Requirement Begins
for Version 3.1.1 of the Clinical Data
Interchange Standards Consortium
Standard for Exchange of Nonclinical
Data Implementation Guide
AGENCY:
Food and Drug Administration,
HHS.
[FR Doc. 2022–03291 Filed 2–11–22; 11:15 am]
ACTION:
BILLING CODE 6715–01–P
Notice.
The Food and Drug
Administration’s (FDA or Agency)
Center for Biologics Evaluation and
Research and (CBER) and Center for
Drug Evaluation and Research (CDER)
are announcing the date that support
begins for version 3.1.1 of the Clinical
Data Interchange Standards Consortium
(CDISC) Standard for Exchange of
Nonclinical Data Implementation Guide
(SENDIG), and the date that this version
update is required in certain
submissions. The Agency will update
the FDA Data Standards Catalog
(Catalog) to reflect these changes.
DATES: Support for version 3.1.1 of the
CDISC SENDIG begins February 15,
2022. The requirement for electronic
submissions to be submitted using
version 3.1.1 of the CDISC SENDIG
begins March 15, 2023, for new drug
applications (NDAs), abbreviated new
drug applications (ANDAs), certain
biologics license applications (BLAs),
and certain investigational new drug
applications (INDs).
ADDRESSES: You may submit either
electronic or written comments at any
time as follows.
SUMMARY:
FEDERAL RETIREMENT THRIFT
INVESTMENT BOARD
Notice of Board Meeting
DATES:
February 23, 2022 at 10:00 a.m.
Telephonic. Dial-in (listen
only) information: Number: 1–415–527–
5035, Code: 2763 825 4435; or via web:
https://tspmeet.webex.com/tspmeet/
onstage/g.php?MTID=e668eeb9f8e4ab
246455527de529d7a2b.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Kimberly Weaver, Director, Office of
External Affairs, (202) 942–1640.
SUPPLEMENTARY INFORMATION:
Board Meeting Agenda
Open Session
1. Approval of the January 24, 2022
Board Meeting Minutes
2. Investment Manager Annual Service
Review
3. Monthly Reports
(a) Participant Activity Report
(b) Investment Performance
(c) Legislative Report
4. Investment Policy Review Frequency
5. Quarterly Report
(d) Metrics
6. Converge Update
7. Agency Recognition
Closed Session
lotter on DSK11XQN23PROD with NOTICES1
8. Information Covered Under 5 U.S.C.
552b(c)(10)
Authority: 5 U.S.C. 552b (e)(1).
Dated: February 10, 2022.
Dharmesh Vashee,
General Counsel, Federal Retirement Thrift
Investment Board.
[FR Doc. 2022–03230 Filed 2–14–22; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
20:12 Feb 14, 2022
Jkt 256001
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
8585
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2022–N–0072 for ‘‘Data Standards;
Requirement Begins for Version 3.1.1 of
the Clinical Data Interchange Standards
Consortium Standard for Exchange of
Nonclinical Data Implementation
Guide.’’ Received comments will be
placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
E:\FR\FM\15FEN1.SGM
15FEN1
Agencies
[Federal Register Volume 87, Number 31 (Tuesday, February 15, 2022)]
[Notices]
[Pages 8584-8585]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03291]
=======================================================================
-----------------------------------------------------------------------
FEDERAL ELECTION COMMISSION
Sunshine Act Meeting
TIME AND DATE: Thursday, February 17, 2022 at 11:00 a.m.
PLACE: 1050 First Street NE, Washington, DC. (This meeting will be a
virtual meeting).
STATUS: This meeting will be closed to the public.
[[Page 8585]]
MATTERS TO BE CONSIDERED: Audit conducted pursuant to 52 U.S.C.
30111(b).
* * * * *
CONTACT PERSON FOR MORE INFORMATION: Judith Ingram, Press Officer.
Telephone: (202) 694-1220.
Authority: Government in the Sunshine Act, 5 U.S.C. 552b.
Laura E. Sinram,
Acting Secretary and Clerk of the Commission.
[FR Doc. 2022-03291 Filed 2-11-22; 11:15 am]
BILLING CODE 6715-01-P